Skip to content

Study · Animal study (in vivo) · rat · 2018

7 results

Humanin Exerts Neuroprotection During Cardiac Ischemia-Reperfusion Injury.

Kumfu S, Charununtakorn ST, Jaiwongkam T, Chattipakorn N, Chattipakorn SC

Journal of Alzheimer's disease : JAD1 Jan 2018Cited by 30 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG at 168 and 252 ug/kg during ischemia, and 252 ug/kg at reperfusion onset, attenuated brain mitochondrial dysfunction.

    In plain wordsIn rats with induced heart injury, a humanin analogue reduced brain mitochondrial damage compared with vehicle.

    Peptide
    Humanin
    Outcome
    DecreaseBrain mitochondrial dysfunction
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG attenuated tau hyperphosphorylation.

    In plain wordsIn rats with induced heart injury, a humanin analogue reduced a brain tau change linked to Alzheimer disease.

    Peptide
    Humanin
    Outcome
    DecreaseTau hyperphosphorylation
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG attenuated brain amyloid-beta accumulation.

    In plain wordsIn rats with induced heart injury, a humanin analogue reduced brain amyloid-beta build-up.

    Peptide
    Humanin
    Outcome
    DecreaseAbeta accumulation
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG attenuated brain apoptosis.

    In plain wordsIn rats with induced heart injury, a humanin analogue reduced brain cell death.

    Peptide
    Humanin
    Outcome
    DecreaseBrain apoptosis
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG did not reduce blood-brain barrier breakdown.

    In plain wordsIn rats with induced heart injury, a humanin analogue did not reduce blood-brain barrier damage.

    Peptide
    Humanin
    Outcome
    No significant changeBlood-brain barrier breakdown
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG did not reduce brain oxidative stress.

    In plain wordsIn rats with induced heart injury, a humanin analogue did not reduce brain oxidative stress.

    Peptide
    Humanin
    Outcome
    No significant changeBrain oxidative stress
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.
  7. 07AnimalAnimal study (in vivo)Efficacy outcome

    In rats with cardiac ischemia-reperfusion injury, HNG did not change brain mitochondrial dynamics.

    In plain wordsIn rats with induced heart injury, a humanin analogue did not change brain mitochondrial dynamics.

    Peptide
    Humanin
    Outcome
    No significant changeBrain mitochondrial dynamics
    Study

    ratn: not reported in source

    Cardiac ischemia-reperfusion injury in male Wistar rats
    Comparator
    Vehicle
    Outcome group
    Mitochondrial function · Nervous system and cognition
    Studied dose
    84, 168 and 252 ug/kg HNG · intravenousAs given in this study (rat).

    Source sentences

    Summary
    HNG at a dose of 168 and 252 μg/kg administered during ischemia, and 252 μg/kg given at the onset of reperfusion effectively attenuated the brain mitochondrial dysfunction, tau hyperphosphorylation and Aβ accumulation, and apoptosis, without reducing BBB breakdown, brain oxidative stress, or mitocho…
    2 context sentences
    Summary · context
    Thirty-six male Wistar rats were divided into two groups: a cardiac I/R group (n = 30), and a sham group (n = 6).
    Summary · context
    The I/R rats were then divided into five subgroups to receive: 1) vehicle; 2) HNG (84 μg/kg); 3) HNG (168 μg/kg); 4) HNG (252 μg/kg) intravenously administered during the cardiac-ischemia; and 5) HNG at 252 μg/kg given at the onset of reperfusion.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.